Annual Retained Earnings
-$487.14 M
-$29.67 M-6.48%
December 31, 2024
Summary
- As of March 11, 2025, YMAB annual retained earnings is -$487.14 million, with the most recent change of -$29.67 million (-6.48%) on December 31, 2024.
- During the last 3 years, YMAB annual retained earnings has fallen by -$146.66 million (-43.08%).
- YMAB annual retained earnings is now -2074.71% below its all-time high of -$22.40 million, reached on December 31, 2016.
Performance
YMAB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$487.14 M
-$6.79 M-1.41%
December 31, 2024
Summary
- As of March 11, 2025, YMAB quarterly retained earnings is -$487.14 million, with the most recent change of -$6.79 million (-1.41%) on December 31, 2024.
- Over the past year, YMAB quarterly retained earnings has stayed the same.
- YMAB quarterly retained earnings is now -1072.10% below its all-time high of -$41.56 million, reached on December 31, 2017.
Performance
YMAB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
YMAB Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.5% | 0.0% |
| 3 y3 years | -43.1% | -11.7% |
| 5 y5 years | -193.7% | -11.7% |
YMAB Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.1% | at low | -43.1% | at low |
| 5 y | 5-year | -193.7% | at low | -193.7% | at low |
| alltime | all time | -2074.7% | at low | -1072.1% | at low |
Y-mAbs Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$487.14 M(+6.5%) | -$487.14 M(+1.4%) |
| Sep 2024 | - | -$480.35 M(+1.5%) |
| Jun 2024 | - | -$473.35 M(+2.0%) |
| Mar 2024 | - | -$464.10 M(+1.4%) |
| Dec 2023 | -$457.47 M(+4.9%) | -$457.47 M(+0.2%) |
| Sep 2023 | - | -$456.48 M(+1.7%) |
| Jun 2023 | - | -$448.74 M(+1.4%) |
| Mar 2023 | - | -$442.43 M(+1.5%) |
| Dec 2022 | -$436.04 M(+28.1%) | -$436.04 M(-0.3%) |
| Sep 2022 | - | -$437.20 M(+6.7%) |
| Jun 2022 | - | -$409.67 M(+11.2%) |
| Mar 2022 | - | -$368.54 M(+8.2%) |
| Dec 2021 | -$340.48 M | -$340.48 M(+12.2%) |
| Sep 2021 | - | -$303.58 M(+10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | -$274.72 M(+9.1%) |
| Mar 2021 | - | -$251.79 M(-11.7%) |
| Dec 2020 | -$285.20 M(+71.9%) | -$285.20 M(+7.5%) |
| Sep 2020 | - | -$265.27 M(+14.1%) |
| Jun 2020 | - | -$232.44 M(+21.0%) |
| Mar 2020 | - | -$192.04 M(+15.8%) |
| Dec 2019 | -$165.86 M(+95.5%) | -$165.86 M(+16.2%) |
| Sep 2019 | - | -$142.73 M(+20.1%) |
| Jun 2019 | - | -$118.81 M(+17.9%) |
| Mar 2019 | - | -$100.77 M(+18.8%) |
| Dec 2018 | -$84.83 M(+104.1%) | -$84.83 M(+19.9%) |
| Sep 2018 | - | -$70.78 M(+19.3%) |
| Jun 2018 | - | -$59.35 M(+42.8%) |
| Dec 2017 | -$41.56 M(+85.5%) | -$41.56 M |
| Dec 2016 | -$22.40 M | - |
FAQ
- What is Y-mAbs Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual retained earnings year-on-year change?
- What is Y-mAbs Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly retained earnings year-on-year change?
What is Y-mAbs Therapeutics annual retained earnings?
The current annual retained earnings of YMAB is -$487.14 M
What is the all time high annual retained earnings for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual retained earnings is -$22.40 M
What is Y-mAbs Therapeutics annual retained earnings year-on-year change?
Over the past year, YMAB annual retained earnings has changed by -$29.67 M (-6.48%)
What is Y-mAbs Therapeutics quarterly retained earnings?
The current quarterly retained earnings of YMAB is -$487.14 M
What is the all time high quarterly retained earnings for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly retained earnings is -$41.56 M
What is Y-mAbs Therapeutics quarterly retained earnings year-on-year change?
Over the past year, YMAB quarterly retained earnings has changed by $0.00 (0.00%)